Intersect ENT, Inc.

    Jurisdiction
    United States
    LEI
    549300SWZUVLSFMOXR50
    ISIN
    US46071F1030 (XENT)
    Sectors
    1. Healthcare
    2. Medical - Devices

    Scores

    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    3 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    3 / 7

    Profile

    Intersect ENT, Inc. operates as an ear, nose, and throat (ENT) medical technology company in the United States. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €89.23M
    Gross margin
    71.9%
    EBIT
    -€128.14M
    EBIT margin
    -143.6%
    Net income
    -€146.26M
    Net margin
    -163.9%

    Statement period: - (published )

    Dividends

    No dividend payouts

    Earnings Calls

    Latest earnings call: May 10, 2021

    Add to watchlist

    Notifications